A global reorganization of drug maker AstraZeneca’s global research and development operations will eliminate 650 U.S. jobs, with 1,200 positions cut at its U.S. headquarters in Wilmington, DE, and hundreds of others shifted to facilities in Maryland and Massachusetts.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
1800 Concord Pike, Wilmington, DE